Ping An Biomedical Co., Ltd. (PASW)
↓ Download CSV- Sector Manufacturing
- Incorporated E9
In fiscal 2025, Ping An Biomedical Co., Ltd. reported revenue of 34.15M CNY, down 61.0% from the prior year. The company ran a net loss, with a net margin of -37.6% and a gross margin of 2.8%. It held 68.41M CNY in total assets against 23.17M CNY in total liabilities.
Key ratios (FY2025)
2.8%
Gross margin
-43.1%
Operating margin
-37.6%
Net margin
-28.4%
Return on equity
-61.0%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | 34.15M CNY | 87.62M CNY | 82.56M CNY | — |
| Cost of Revenue | 33.20M CNY | 82.21M CNY | 78.32M CNY | — |
| Gross Profit | 949.5K CNY | 5.42M CNY | 4.24M CNY | — |
| Operating Income | -14.70M CNY | -2.0K CNY | 612.5K CNY | — |
| Net Income | -12.83M CNY | -1.28M CNY | -993.9K CNY | — |
| EPS (Diluted) | -0.69 CNY | -0.07 CNY | -0.06 CNY | — |
| Total Assets | 68.41M CNY | 56.85M CNY | — | — |
| Total Liabilities | 23.17M CNY | 64.04M CNY | — | — |
| Shareholders' Equity | 45.24M CNY | -7.19M CNY | -5.86M CNY | 4.60M CNY |
| Cash & Equivalents | 1.17M CNY | 130.9K CNY | 591.9K CNY | — |
| Operating Cash Flow | -6.43M CNY | 14.63M CNY | -6.08M CNY | — |
| Shares Outstanding | 18.48M | 18.00M | 18.00M | — |